John M. Kittelson

Rivaroxaban in Peripheral Artery Disease after Revascularization

Marc P. Bonaca, Rupert Bauersachs, Sonia S. Anand et al. · New England Journal of Medicine · 2020 · 926 citations · Full text

Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.

Powell Wc, Knox Jd, Marc Navre et al. · PubMed · 1993 · 202 citations

Immunology, Immune Regulation, Immunologic Mechanism +23

A Randomized Trial of Modafinil for the Treatment of Fatigue and Excessive Daytime Sleepiness in Individuals with Chronic Traumatic Brain Injury

Amitabh Jha, Alan Weintraub, Amanda A. Allshouse et al. · Journal of Head Trauma Rehabilitation · 2008 · 163 citations

Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma.

Raymond B. Nagle, M K Brawer, John M. Kittelson et al. · PubMed · 1991 · 131 citations · Full text

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)

Warren H. Capell, Marc P. Bonaca, Mark R. Nehler et al. · American Heart Journal · 2018 · 129 citations

Endovascular Technique, Cardiovascular Disease, Peripheral Intervention +11